Otello Stampacchia

This profile gathers the share dealings of Otello Stampacchia across 4 companies, led by ImageneBio, Inc., Kronos Bio, Inc. and Morphic Holding, Inc. In total, 12 filings cover trades dated from 1 July 2019 to 25 July 2025.

Every open-market trade on record is a purchase: 4 purchases worth €20.0M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant and 1 option exercise. Since January 2025: 1 purchase and no sales on the market.

In size, the median ticket on the buying side is €5.5M. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

On 30 July 2025 came the latest disclosure, an open-market purchase for €6.8M in ImageneBio, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.